Retroviral-Mediated Gene Transfer of CD34-Enriched Bone Marrow and Peripheral Blood Cells During Autologous Stem Cell Transplantation for Multiple Myeloma. Huddinge Hospital and Karolinska Institute, Huddinge, Sweden

This publication has 14 references indexed in Scilit:

• High-dose chemoradiotherapy and autologous blood stem cell transplantation in multiple myeloma: results of a phase II trial involving 63 patients
  Blood, 1993
• Use of Two Retroviral Markers to Test Relative Contribution of Marrow and Peripheral Blood Autologous Cells to Recovery After Preparative Therapy. The University of Texas M.D. Anderson Cancer Center
  Human Gene Therapy, 1993
• Gene-marking to trace origin of relapse after autologous bone-marrow transplantation
  The Lancet, 1993
• Factors affecting the transduction of pluripotent hematopoietic stem cells: long-term expression of a human adenosine deaminase gene in mice
  Blood, 1993
• Transfer of the ADA gene into human ADA-deficient T lymphocytes reconstitutes specific immune functions
  Blood, 1992
• Retrovirus-Mediated Gene Transfer as an Approach to Analyze Neuroblastoma Relapse after Autologous Bone Marrow Transplantation
  Human Gene Therapy, 1992
• Immunologic Purging of Marrow Assessed by PCR before Autologous Bone Marrow Transplantation for B-Cell Lymphoma
  New England Journal of Medicine, 1991
• Allogeneic Bone Marrow Transplantation in Multiple Myeloma
  New England Journal of Medicine, 1991
• Autologous Bone Marrow Transplant for Children with AML in First Complete Remission: Use of Marker Genes to Investigate the Biology of Marrow Reconstitution and the Mechanism of Relapse
  Human Gene Therapy, 1991
• Treatment for Multiple Myeloma
  JAMA, 1969